Mesothelioma: Mortality Rates

(asked on 4th September 2023) - View Source

Question to the Department of Health and Social Care:

To ask His Majesty's Government what were the survival rates for people diagnosed of mesothelioma in each of the five years up to December 2022.


Answered by
Lord Markham Portrait
Lord Markham
Parliamentary Under-Secretary (Department of Health and Social Care)
This question was answered on 13th September 2023

The latest mesothelioma cancer survival statistics available are for those adults diagnosed between 2016-2020, followed up to 2021.

The table below provides the year of cancer diagnosis, the years since diagnosis (from 1 to 5), and the respective survival rates, with associated 95% upper and lower confidence intervals (CIs). Where estimates are not possible due to low reliability, a [u] is shown.

Year of diagnosis

Years since diagnosis

Net survival (%)

Net survival, lower 95% CI

Net survival, upper 95% CI

2016-2020

1

46.0

44.7

47.4

2015-2019

1

46.0

44.8

47.3

2014-2018

1

45.3

44.0

46.7

2013-2017

1

44.7

43.5

46.0

2012-2016

1

44.5

43.2

45.7

2016-2020

2

24.1

23.0

25.2

2015-2019

2

23.6

22.5

24.7

2014-2018

2

23.1

22.0

24.1

2013-2017

2

21.7

20.7

22.8

2012-2016

2

21.4

20.4

22.4

2016-2020

3

14.7

13.8

15.7

2015-2019

3

14.3

13.4

15.2

2014-2018

3

13.8

12.9

14.7

2013-2017

3

12.8

12.0

13.7

2012-2016

3

12.2

11.4

13.1

2016-2020

4

10.0

9.1

10.9

2015-2019

4

9.6

8.7

10.5

2014-2018

4

9.4

8.6

10.3

2013-2017

4

8.3

7.4

9.2

2012-2016

4

7.6

6.8

8.5

2016-2020

5

[u]

[u]

[u]

2015-2019

5

7.1

6.2

8

2014-2018

5

7.1

6.3

8.1

2013-2017

5

6.6

5.8

7.6

2012-2016

5

[u]

[u]

[u]

This information is provided as survival estimates in rolling five-year periods because there are insufficient diagnoses of mesothelioma to provide estimates by a single year of diagnosis. This is because of the statistical frameworks used in the estimation of survival analysis which require minimum numbers of patients to be alive at each estimation point and for a minimum number to have died around the same time to reliably estimate the mortality rates of the cancer cohort. For cancers like mesothelioma, the number of patients remaining alive quickly falls to a number that no longer permits the estimation of survival beyond 5-years after diagnosis, shown as [u] in the table to detonate low reliability.

Furthermore, all estimates of survival vary with time from diagnosis. We have provided estimates at one, two, three, four and five years after diagnosis for five periods of diagnosis: 2012-2016 to 2016-2020, which is the most recent available.

Reticulating Splines